1 enrolling by invitation. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Pulmonary Emphysema: new trials by email Literature Review of Pulmonary Emphysema trials Research Report on Pulmonary Emphysema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency Alpha-1 MP - Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency | Phase 3 | Enrolling by invitation | Grifols Therapeutics LLC | 290 | 2016-07-01 | 2026-06-23 |
alpha 1-Antitrypsin Deficiency (1)
Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Disease Attributes (1) · Emphysema (1) · Genetic Diseases, Inborn (1) · Liver Diseases (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pulmonary Disease, Chronic Obstructive (1) · Respiratory Tract Diseases (1) · Subcutaneous Emphysema (1)
Australia (1) · Canada (1) · Denmark (1) · Estonia (1) · Finland (1) · France (1) · Moldova (1) · New Zealand (1) · Poland (1) · Russia (1) · Sweden (1) · United States (1)